Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle

Hepatitis C virus (HCV) NS3 protease inhibitors (PIs) are important components of novel HCV therapy regimens. Studies of PI resistance initially focused on genotype 1. Therefore, knowledge about the determinants of PI resistance for the highly prevalent genotypes 2 to 6 remains limited. Using Huh7.5...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Serre, Stéphanie B. N., Jensen, Sanne B., Ghanem, Lubna, Humes, Daryl G., Ramirez, Santseharay, Li, Yi-Ping, Krarup, Henrik, Bukh, Jens, Gottwein, Judith M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2016
Предметы:
Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879388/
https://ncbi.nlm.nih.gov/pubmed/27021330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02929-15
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы